- Home
- MEDP vs SUZ Comparison
MEDP vs SUZ Comparison
Compare MEDP & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- SUZ
- Stock Information
- Founded
- MEDP 1992
- SUZ 1924
- Country
- MEDP United States
- SUZ Brazil
- Employees
- MEDP N/A
- SUZ N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- SUZ Paper
- Sector
- MEDP Health Care
- SUZ Basic Materials
- Exchange
- MEDP Nasdaq
- SUZ Nasdaq
- Market Cap
- MEDP 10.5B
- SUZ 12.8B
- IPO Year
- MEDP 2016
- SUZ N/A
- Fundamental
- Price
- MEDP $341.15
- SUZ $10.07
- Analyst Decision
- MEDP Buy
- SUZ
- Analyst Count
- MEDP 10
- SUZ 0
- Target Price
- MEDP $389.00
- SUZ N/A
- AVG Volume (30 Days)
- MEDP 257.2K
- SUZ 2.2M
- Earning Date
- MEDP 02-10-2025
- SUZ 10-24-2024
- Dividend Yield
- MEDP N/A
- SUZ 2.36%
- EPS Growth
- MEDP 33.84
- SUZ N/A
- EPS
- MEDP 11.42
- SUZ 0.60
- Revenue
- MEDP $2,070,866,000.00
- SUZ $8,006,653,403.00
- Revenue This Year
- MEDP $13.95
- SUZ $14.70
- Revenue Next Year
- MEDP $5.82
- SUZ $10.62
- P/E Ratio
- MEDP $30.00
- SUZ $16.02
- Revenue Growth
- MEDP 16.24
- SUZ N/A
- 52 Week Low
- MEDP $277.72
- SUZ $8.78
- 52 Week High
- MEDP $459.77
- SUZ $12.98
- Technical
- Relative Strength Index (RSI)
- MEDP 50.57
- SUZ 43.46
- Support Level
- MEDP $326.92
- SUZ $9.62
- Resistance Level
- MEDP $342.73
- SUZ $10.17
- Average True Range (ATR)
- MEDP 10.02
- SUZ 0.20
- MACD
- MEDP -0.51
- SUZ -0.07
- Stochastic Oscillator
- MEDP 45.26
- SUZ 29.04
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.